Meat Consumption Linked with Higher Risk of Developing Type 2 Diabetes
Drug Topics
AUGUST 21, 2024
Increased incidence of typed 2 diabetes was associated with higher consumption of processed meat, unprocessed red meat, and poultry.
Wed.Aug 21, 2024
199 
Long Covid symptoms in kids aren’t one-size-fits-all, study shows
STAT
AUGUST 21, 2024
Rachel Gross wants to clear up misconceptions about children and Covid-19. A pediatrician and population health researcher, she recalls a time four years ago when people didn’t think children could even contract the disease. Then, after accepting kids’ vulnerability to the virus, it was thought only adults could suffer from the myriad symptoms that persist or crop up post-infection, collectively known as long Covid.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Tirzepatide Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT-1 Study
Drug Topics
AUGUST 21, 2024
A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.
There’s a knowledge gap about miscarriages in the U.S., and researchers hope to close it
STAT
AUGUST 21, 2024
Megan Hanson was eight weeks pregnant in 2019 when she experienced a miscarriage — her sixth consecutive loss in as many years. It felt particularly cruel after a second IVF transfer. She and her husband, Ben Burnham, were devastated, physically and financially drained — and deeply frustrated by the lack of answers or support for people like them who had experienced recurrent miscarriages.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Q&A: Discussing the Dangers of Buying GLP-1s From Online Pharmacies
Drug Topics
AUGUST 21, 2024
Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms.
Opinion: Doing more cancer screening won’t reduce Black-white health disparities
STAT
AUGUST 21, 2024
For years, Black Americans have been more likely to die of cancer than white Americans. There is a widespread belief that cancer screening — tests to detect hidden cancer — can reduce this Black-white disparity. While it is important to be attentive to racial disparities in health and health care, the belief in screening is misguided. More cancer screening primarily serves the interests of the health care system, not those of Black Americans.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Alzheimer’s drug may raise the risk of brain bleed in patients with Down syndrome
STAT
AUGUST 21, 2024
A year ago, after much fanfare and controversy , the Food and Drug Administration approved Eisai and Biogen’s lecanemab, an anti-amyloid drug that moderately slowed cognitive decline in patients with Alzheimer’s disease. But doctors have been hesitant to prescribe the drug and its pharmacological cousin, Eli Lilly’s donanemab, for people with Down syndrome because of a lack of safety data.
Proposed Bill Requires States to Use Opioid Settlement Funds to Address the Opioid Epidemic
Pharmacy Times
AUGUST 21, 2024
The money could be used for prevention and treatment services, health care practitioner training, or other ways to stem the epidemic.
CMS closes thousands of No Surprises Act complaints, directs $4M in relief
Fierce Healthcare
AUGUST 21, 2024
The Centers for Medicare & Medicaid Services (CMS) issued a new report Tuesday detailing total complaints related to the No Surprises Act and Affordable Care Act compliance. | A new CMS report outlines the types of No Surprises Act complaints resolved by the federal agency since June 30.
Overturning Chevron Deference Could Lead to Confusion, Chaos Across Pharmaceutical Industry
Pharmacy Times
AUGUST 21, 2024
The decision by the Supreme Court has the potential to upend the power of regulatory agencies to shape the health care landscape of the country.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Federal judge blocks FTC's nationwide noncompete ban
Fierce Healthcare
AUGUST 21, 2024
A Texas federal judge has struck down the Federal Trade Commission’s rule broadly banning employers’ noncompete agreements 15 days before it was set to go into effect nationwide. | U.S. District Judge Ada Brown ruled that the FTC exceeded its statutory authority and failed to present sufficient evidence for its sweeping ban. Mixed rulings among other district courts and comments from a regulator spokesperson suggest an appeal is likely.
Physician Shortage Provides Opportunity for Pharmacists to Step Up
Drug Topics
AUGUST 21, 2024
However, reimbursement for these services for pharmacists remains a crucial issue.
Biogen sued for alleged PBM kickbacks scheme to boost Tecfidera in wake of generics
Fierce Pharma
AUGUST 21, 2024
As Biogen’s relentless patent defense for blockbuster multiple sclerosis med Tecfidera came up short in the U.S., the company separately worked to fend off competition through an anticompetitive ki | A multi-employer health benefit plan in Illinois accused the drugmaker of scheming with pharmacy benefit managers to keep its Tecfidera in a more favorable spot on their formularies.
Ask NAVLIN: The AI chatbot innovation driving a better global customer experience
pharmaphorum
AUGUST 21, 2024
Demonstrating EVERSANA's dedication to innovation, a novel artificial intelligence technology is set to enhance the NAVLIN experience for both current and prospective customers.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Sustainability is increasingly important in pharma, but several hurdles are slowing the effort: survey
Fierce Pharma
AUGUST 21, 2024
A survey of 800 biopharma executives shows that sustainability is an increasingly important priority but that companies are struggling to achieve it.
Majority of Savings from CMS Price Negotiations Comes From 3 Drugs
Drug Topics
AUGUST 21, 2024
Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.
Methotrexate and Bactrim – Important Drug Interaction
Med Ed 101
AUGUST 21, 2024
EJ is a 54-year-old female with a history of rheumatoid arthritis. She has been on methotrexate (with folic acid supplementation) for years with relatively few RA flares over the last 10 years. She was recently diagnosed with a urinary tract infection and was prescribed sulfamethoxazole/trimethoprim (Bactrim). What concerns should we have regarding the methotrexate and […] The post Methotrexate and Bactrim – Important Drug Interaction appeared first on Med Ed 101.
STAT+: Pharmalittle: We’re reading about obesity drugs and suicidal thoughts, a FDA official’s conflicts, and more
STAT
AUGUST 21, 2024
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is now upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not particularly appealing. So what better way to make the time fly than to keep busy.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Tackling the Prior Authorization Problem with Innovative Technologies
Fierce Healthcare
AUGUST 21, 2024
By: Christie Callahan, Chief Operating Officer, Arrive Health | Tackling the Prior Authorization Problem with Innovative Technologies
Study reignites debate on GLP-1 drugs and suicide risk
pharmaphorum
AUGUST 21, 2024
Debate over the safety of GLP-1 drugs resurfaces after study finds 'disproportional' risk of suicidal thinking adverse event reports with Novo Nordisk's semaglutide
Understanding Pharmacy Deserts: How Can We Impact This Growing Trend?
Pharmacy Times
AUGUST 21, 2024
When a community loses a pharmacy, it loses a trusted health care provider. Understanding the root causes of these closures—and what we can do about it—can drive change.
Medicare plans accuse Teva of covering copays for patients
pharmaphorum
AUGUST 21, 2024
A class action suit has been filed in the US against Teva, claiming that the company illegally subsidised the copays for patients prescribed its multiple sclerosis therapy Copaxone to boost its sales.The suit filed on behalf of Medicare Advantage coverage providers accuses the company of "funnelling hundreds of millions of dollars" to Copaxone (glatiramer acetate) patients through third-party foundations and companies.
Astellas employee held in China indicted by China’s prosecutors: Reuters
Fierce Pharma
AUGUST 21, 2024
More than a year after detaining an employee of Astellas for suspected spying, Chinese authorities have indicted the Japanese expat,
J&J's Rybrevant okay challenges Tagrisso in first-line NSCLC
pharmaphorum
AUGUST 21, 2024
J&J's Rybrevant/Lazcluze combination is cleared by FDA for first-line EGFR+ NSCLC, giving AstraZeneca's top-seller Tagrisso its first direct competition
NACDS President: Technological Innovation, Policy Initiatives Key Focuses for Future
Pharmacy Times
AUGUST 21, 2024
President of NACDS, Steve Anderson, discusses how the events at Total Store Expo reflect on the association's goals of innovation and a focus on public policy.
Aadi lays off 80% of R&D workforce as Fyarro heads to phase 2 solid tumor fail
Fierce Pharma
AUGUST 21, 2024
Aadi Bioscience’s Fyarro is on track to fail a phase 2 solid tumor trial, leading the biotech to halt the study and lay off 80% of its R&D workforce.
Study Finds Ketogenic Diets May Increase “Bad” Cholesterol
Pharmacy Times
AUGUST 21, 2024
Pharmacists are key resource points to navigate the nuances of keto diets and chronic health management.
Despite trial scare, Travere’s Filspari gains full FDA nod in kidney disease showdown with Novartis
Fierce Pharma
AUGUST 21, 2024
A year after missing on a trial endpoint, Travere Therapeutics can breathe a sigh a relief. | A year after missing on a trial endpoint, Travere Therapeutics can breathe a sigh a relief. The FDA has converted Filspari’s conditional nod in the kidney disease IgAN into a full approval but left a liver toxicity monitoring requirement in place.
Study: Biosimilar Etanercept Shows Equivalence With Reference Product for Rheumatoid Arthritis
Pharmacy Times
AUGUST 21, 2024
Biosimilar etanercept (Sunshine Guojian Pharmaceutical) showed similar therapeutic outcomes compared with etanercept (Enbrel; Amgen) specific to rheumatoid arthritis.
Amgen’s Otezla launched for paediatric plaque psoriasis in US
Pharmaceutical Technology
AUGUST 21, 2024
Amgen has announced the availability of Otezla (apremilast) in the US for paediatric patients with moderate to severe plaque psoriasis.
Can you take biotin and Synthroid together?
The Checkup by Singlecare
AUGUST 21, 2024
Many people taking Synthroid (levothyroxine) for thyroid problems might also take biotin to supplement their health or to manage Synthroid side effects like hair loss. While biotin is known for its benefits for hair and nails, there are potential interactions to consider if you’re taking thyroid medication. Biotin can interfere with thyroid function tests, causing misleading results and possibly affecting your treatment plan.
NMPA approves AstraZeneca’s Fasenra for severe asthma
Pharmaceutical Technology
AUGUST 21, 2024
The China NMPA approved AstraZeneca's Fasenra for individuals aged 12 years and older with severe eosinophilic asthma (SEA).
How can digital technologies help pharma meet the changing needs of HCPs and patients?
pharmaphorum
AUGUST 21, 2024
Digital technologies play a crucial role in helping the pharmaceutical industry meet the changing needs of healthcare providers (HCPs) and patients. Learn how digital innovations are transforming healthcare delivery and improving patient outcomes in this comprehensive guide.
Let's personalize your content